Drug
ASP2151 clinical trials
Also written ASP2151.
- studies test it
- 13
- open now
- 0
- in phase 3
- 3
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
- ASP2151
- 12
Studies by the year they started
13 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 2
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 0
Maruho Europe Limited (5) · Astellas Pharma Inc (4) · Maruho Co., Ltd. (3) · Astellas Pharma Europe Ltd. (1)
Often tested with
Tested in the same studies.
Montelukast (1) · Ritonavir (1) · Bupropion (1) · Midazolam (1) · Valacyclovir (1)
Studies
Open first, then newest update. How each study uses ASP2151 is read from its arms, and is right about nine times in ten.
Testing it · 13
- Phase III Study of ASP2151 in Herpes Simplex PatientsCompletedPhase 3Maruho Co., Ltd.NCT01959295Written as ASP2151
- Open-label Study of ASP2151 in Herpes Simplex PatientsCompletedPhase 3Maruho Co., Ltd.NCT02209324Written as ASP2151
- Drug-Drug Interaction Study: ASP2151 and CiclosporinCompletedPhase 1Maruho Europe LimitedNCT02280421Written as ASP2151 400mg + 100mg ciclosporin
- Drug-Drug Interaction Study: ASP2151 and MontelukastCompletedPhase 1Maruho Europe LimitedNCT02321748Written as ASP2151
- Drug-Drug Interaction Study: ASP2151 and RitonavirCompletedPhase 1Maruho Europe LimitedNCT02223351Written as ASP2151
- Drug-Drug Interaction Study: ASP2151 and BupropionCompletedPhase 1Maruho Europe LimitedNCT02369172Written as ASP2151
- Drug-Drug Interaction Study: ASP2151 and MidazolamCompletedPhase 1Maruho Europe LimitedNCT02403635Written as ASP2151
- Phase III Study of ASP2151 in Herpes Zoster PatientsCompletedPhase 3Maruho Co., Ltd.NCT01959841Written as ASP2151
- Dose-finding Study of ASP2151 in Subjects With Herpes ZosterCompletedPhase 2Astellas Pharma IncNCT00487682Written as ASP2151
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedPhase 2Astellas Pharma IncNCT00486200Written as ASP2151
- Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly SubjectsCompletedPhase 1Astellas Pharma IncNCT02796118Written as ASP2151
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodCompletedPhase 1Astellas Pharma Europe Ltd.NCT02852876Written as ASP2151
- Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy VolunteersTerminatedPhase 1Astellas Pharma IncNCT00870441Written as ASP2151